• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对源自膀胱移行细胞癌的U-BLC1细胞系进行详细的标记染色体分析。

Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.

作者信息

Bruch J, Wöhr G, Brüderlein S, Barbi G, Wolter H, Dixkens C, Mattfeldt T, Möller P, Paiss T, Hautmann R, Vogel W, Hameister H

机构信息

Department of Medical Genetics, University of Ulm, Germany.

出版信息

Int J Cancer. 1999 Mar 15;80(6):903-10. doi: 10.1002/(sici)1097-0215(19990315)80:6<903::aid-ijc17>3.0.co;2-8.

DOI:10.1002/(sici)1097-0215(19990315)80:6<903::aid-ijc17>3.0.co;2-8
PMID:10074925
Abstract

A permanent cell line, U-BLC1, was established from a primary transitional-cell carcinoma, TCC, of the urinary bladder. Karyotype analysis showed the line to be highly aberrant, with a near-triploid chromosome number of 68 to 73. Comparative genomic hybridization revealed some distinct differences between the primary tumor and the established cell line. Karyotype analysis showed 3 marker chromosomes with homogeneously staining regions, HSRs, in the cell line. The HSRs were isolated by microdissection and the microdissection probes were hybridized to normal metaphase chromosomes. The HSRs contain sequences known to be frequently involved in amplification in transitional-cell carcinoma of the bladder, 6p22, 7p11-p12, 9p23-pter, and one region not yet reported to be amplified in primary TCC of the bladder, 1p31-p32. A candidate-gene approach showed that in the region 7p11-p12 the EGFR locus is amplified and highly expressed.

摘要

一个永久性细胞系U - BLC1是从膀胱原发性移行细胞癌(TCC)建立的。核型分析表明该细胞系高度异常,染色体数接近三倍体,为68至73条。比较基因组杂交显示原发性肿瘤与建立的细胞系之间存在一些明显差异。核型分析显示该细胞系中有3条带有均匀染色区(HSRs)的标记染色体。通过显微切割分离出HSRs,并将显微切割探针与正常中期染色体杂交。HSRs包含已知在膀胱移行细胞癌中频繁参与扩增的序列,6p22、7p11 - p12、9p23 - pter,以及一个尚未报道在膀胱原发性TCC中扩增的区域,1p31 - p32。候选基因方法表明在7p11 - p12区域,表皮生长因子受体(EGFR)基因座被扩增并高表达。

相似文献

1
Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.对源自膀胱移行细胞癌的U-BLC1细胞系进行详细的标记染色体分析。
Int J Cancer. 1999 Mar 15;80(6):903-10. doi: 10.1002/(sici)1097-0215(19990315)80:6<903::aid-ijc17>3.0.co;2-8.
2
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.膀胱癌细胞系中6p22扩增单元的描绘
Cancer Res. 2000 Aug 15;60(16):4526-30.
3
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
Cancer Genet Cytogenet. 2002 Jun;135(2):139-46. doi: 10.1016/s0165-4608(01)00648-3.
4
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?9号染色体缺失是膀胱移行细胞癌疾病复发的标志物吗?
Br J Cancer. 1998 Jun;77(12):2193-8. doi: 10.1038/bjc.1998.365.
5
Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.通过荧光原位杂交检测到的膀胱癌基因组异质性。
Br J Urol. 1996 Nov;78(5):699-703. doi: 10.1046/j.1464-410x.1996.01786.x.
6
[Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].[应用多色荧光原位杂交技术检测膀胱尿路上皮癌]
Ai Zheng. 2007 Feb;26(2):189-93.
7
Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.膀胱鳞状细胞癌和移行细胞癌中7号、9号和17号染色体的数值畸变:一项通过荧光原位杂交进行的比较研究
J Urol. 1998 Sep;160(3 Pt 1):737-40. doi: 10.1016/S0022-5347(01)62772-1.
8
Identification of a tumor marker chromosome by flow sorting, DNA amplification in vitro, and in situ hybridization of the amplified product.
Genes Chromosomes Cancer. 1993 Jan;6(1):10-6. doi: 10.1002/gcc.2870060104.
9
6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.6p22.3扩增作为晚期膀胱癌的生物标志物和潜在治疗靶点。
Oncotarget. 2013 Nov;4(11):2124-34. doi: 10.18632/oncotarget.1485.
10
Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
Int J Clin Lab Res. 2000;30(1):5-11. doi: 10.1007/s005990070026.

引用本文的文献

1
HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways.HOXA13通过抑制抗原加工与呈递以及吞噬体途径促进膀胱癌的免疫逃逸。
Funct Integr Genomics. 2025 Feb 24;25(1):44. doi: 10.1007/s10142-025-01553-w.